Scholarly Index
Arlene O. Siefker‐Radtke
The University of Texas MD Anderson Cancer Center; 19,622 total citations; 336 total publications; best world rank #17
The University of Texas MD Anderson Cancer Center
19,622Total citations
336Total publications
64H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Urinary and Genital Oncology Studies | Lifetime | 64 | US 38 | 99.42 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 117 | US 73 | 99.39 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 525 | US 267 | 98.82 |
| Urological Disorders and Treatments | Lifetime | 579 | US 322 | 97.83 |
| Fibroblast Growth Factor Research | Lifetime | 231 | US 108 | 96.43 |
| Renal cell carcinoma treatment | Lifetime | 797 | US 403 | 96.97 |
| Multiple and Secondary Primary Cancers | Lifetime | 447 | US 195 | 95.76 |
| Infectious Disease Case Reports and Treatments | Lifetime | 214 | US 116 | 85.51 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 80 | US 34 | 98.83 |
| Fibroblast Growth Factor Research | 2021-2025 | 17 | US 11 | 97.29 |
| Urinary and Genital Oncology Studies | 2021-2025 | 60 | US 27 | 98.23 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 908 | US 333 | 96.50 |